Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: A cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Penno, Giuseppe ^a   Solini, Anna ^a   Zoppini, Giacomo ^b   Orsi, Emanuela ^c   Fondelli, Cecilia ^d   Zerbini, Gianpaolo ^e   Morano, Susanna ^f   Cavalot, Franco ^g   Lamacchia, Olga ^h   Trevisan, Roberto ⁱ   Vedovato, Monica ^j   Pugliese, Giuseppe ^f  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF FOGGIA   (Italy)

ⁱ Hospital of Bergamo   (Italy)

^j UNIVERSITY OF PADOVA   (Italy)

more..

Author keywords

Chronic kidney disease; Hemoglobin A1c; Retinopathy; Risk factors; Type 2 diabetes

Indexed keywords

CREATININE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY BLOOD VESSEL; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY (TOPIC); NEPHELOMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; PREDICTIVE VALUE; TURBIDIMETRY; BLOOD; COHORT ANALYSIS; COMPLICATION; DIABETIC NEPHROPATHY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84879819683     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-98     Document Type: Article

References (34)

1. The DCCT Research Group The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996, 45:1289-1298. The DCCT Research Group.
2. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405-412. 10.1136/bmj.321.7258.405, 27454, 10938048.
3. DCCT Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329:977-986. DCCT Research Group.
4. UKPDS The Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:837-853. UKPDS The Group.
5. The DCCT/EDIC Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005, 353:2643-2653. 2637991, 16371630, The DCCT/EDIC Study Research Group.
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589. 10.1056/NEJMoa0806470, 18784090.
7. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN for the DCCT/EDIC Research Group Effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trial-Revisited. Diabetes 2008, 57:995-1001. 10.2337/db07-1618, 18223010, Rutledge BN for the DCCT/EDIC Research Group.
8. Home PD. Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes. Curr Med Res Opin 2005, 21:989-998. 10.1185/030079905X49662, 16004665.
9. Kilpatrick ES. The rise and fall of HbA1c as a risk marker for diabetes complications. Diabetologia 2012, 55:2089-2091. 10.1007/s00125-012-2610-5, 22711013.
10. Standl E, Schnell O, Ceriello A. Postprandial hyperglycemia and glycemic variability. Diabetes Care 2011, 34(Suppl 2):S120-S127. 3632148, 21525442.
11. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006, 29:1486-1490. 10.2337/dc06-0293, 16801566.
12. Kilpatrick ES, Rigby AS, Atkin SL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009, 32:1901-1903. 10.2337/dc09-0109, 2752912, 19549736.
13. Siegelaar SE, Kilpatrick ES, Rigby AS, Atkin SL, Hoekstra JB, Devries JH. Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia 2009, 52:2229-2232. 10.1007/s00125-009-1473-x, 2744825, 19672575.
14. Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, Jacober SJ. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care 2009, 32:381-386. 10.2337/dc08-1671, 2646013, 19246588.
15. Siegelaar SE, Kerr L, Jacober SJ, Devries JH. A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: a reanalysis of the HEART2D study. Diabetes Care 2011, 34:855-857. 10.2337/dc10-1684, 3064040, 21447661.
16. Raz I, Ceriello A, Wilson PW, Battioui C, Su EW, Kerr L, Jones CA, Milicevic Z, Jacober SJ. Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemia. Diabetes Care 2011, 34:1511-1513. 10.2337/dc10-2375, 3120208, 21593301.
17. Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, Zhou Y, Ma C. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2011, 10:19. 10.1186/1475-2840-10-19, 3056765, 21349201.
18. Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 2008, 31:2198-202. 10.2337/dc08-0864, 2571045, 18650371.
19. Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH, Finnish Diabetic Nephropathy Study Group A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes 2009, 58:2649-2655. 10.2337/db09-0693, 2768180, 19651819, Finnish Diabetic Nephropathy Study Group.
20. Marcovecchio ML, Dalton RN, Chiarelli F, Dunger DB. A1C variability as an independent risk factor for microalbuminuria in young people with type 1 diabetes. Diabetes Care 2011, 34:1011-1013. 10.2337/dc10-2028, 3064014, 21335371.
21. Sugawara A, Kawai K, Motohashi S, Saito K, Kodama S, Yachi Y, Hirasawa R, Shimano H, Yamazaki K, Sone H. HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2. Diabetologia 2012, 55:2128-2131. 10.1007/s00125-012-2572-7, 22580991.
22. Hsu CC, Chang HY, Huang MC, Hwang SJ, Yang YC, Lee YS, Shin SJ, Tai TY. HbA(1c) variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study. Diabetologia 2012, 55:3163-3172. 10.1007/s00125-012-2700-4, 22923064.
23. Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Morano S, Cavalot F, Lamacchia O, Laviola L, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Care 2013, epub Mar 14, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
24. Prince CT, Becker DJ, Costacou T, Miller RG, Orchard TJ. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia 2007, 50:2280-2288. 10.1007/s00125-007-0797-7, 17768606.
25. Luk AO, Ma RC, Lau ES, Yang X, Lau WW, Yu LW, Chow FC, Chan JC, So WY. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: Prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab Res Rev 2013, e-pub Mar 6.
26. Solini A, Penno G, Bonora E, Fondelli C, Orsi E, Arosio M, Trevisan R, Vedovato M, Cignarelli M, Andreozzi F, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Care 2012, 35:143-149. 10.2337/dc11-1380, 3241302, 22124714, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
27. Pugliese G, Solini A, Fondelli C, Trevisan R, Vedovato M, Nicolucci A, Penno G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) Study. Nephrol Dial Transpl 2011, 26:3950-3954. Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
28. Pugliese G, Solini A, Bonora E, Orsi E, Zerbini G, Giorgino F, Cavalot F, Pontiroli AE, Baroni MG, Morano S, Nicolucci A, Penno G. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. Atherosclerosis 2011, 218:194-199. 10.1016/j.atherosclerosis.2011.04.035, 21612781.
29. Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Trevisan R, Vedovato M, Gruden G, Cavalot F, Cignarelli M, Laviola L, Morano S, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 2011, 29:1802-1809. 10.1097/HJH.0b013e3283495cd6, 21738053, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
30. National Kidney Foundation KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266. National Kidney Foundation.
31. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy Project Group Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682. 10.1016/S0161-6420(03)00475-5, 13129861, Global Diabetic Retinopathy Project Group.
32. Penno G, Solini A, Zoppini G, Orsi E, Zerbini G, Trevisan R, Gruden G, Cavalot F, Laviola L, Morano S, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care 2012, 35:2317-2123. 10.2337/dc12-0628, 23093684, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
33. Martins RA, Jones JG, Cumming SP, Coelho e Silva MJ, Teixeira AM, Veríssimo MT. Glycated hemoglobin and associated risk factors in older adults. Cardiovasc Diabetol 2012, 11:13. 10.1186/1475-2840-11-13, 3395860, 22309488.
34. Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Trevisan R, Vedovato M, Gruden G, Laviola L, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J Intern Med 2013, 274:176-191. 10.1111/joim.12073, 23565931, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.